Evidence map›Paper›PMID 32503932›Full record

ArticleThe British journal of ophthalmology2021

Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study.

Juan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, Maureen G Maguire, Ebenezer Daniel, Revell Whittock-Martin, Candace Parker-Ostroff, Douglas Jacoby, Alan S Go, Raymond R Townsend and 8 more

Open access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in The British journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Diabetic Retinopathy and Cardiovascular Disease: A Literature Review [Response to Letter].Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Juan E GrunwaldOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA juan.grunwald@uphs.upenn.edu.ORCID 0000-0002-5973-6616
Maxwell PistilliOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Gui-Shuang YingOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Maureen G MaguireOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ebenezer DanielOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Revell Whittock-MartinOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Candace Parker-OstroffOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Douglas JacobyOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alan S GoDepartment of Research, Kaiser Permanente, Oakland, California, USA.
Raymond R TownsendOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Crystal Ann GadegbekuMedicine, Temple University Hospital, Philadelphia, Pennsylvania, USA.
James P LashMedicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Jeffrey Craig FinkDepartment of Medicine, University of Maryland Baltimore County, Baltimore, Maryland, USA.
Mahboob RahmanMedicine, Case Western Reserve University, Cleveland, Ohio, USA.
Harold FeldmanOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
John W KusekOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Dawei XieOphthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
CRIC Study investigators
University of Pennsylvania · USCase Western Reserve University · USKaiser Permanente · USTemple University Hospital · USUniversity of Illinois Chicago · USUniversity of Maryland, Baltimore County · USUniversity of Pennsylvania Health System · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Scientific and Data Coordinating Center(SDCC) for the P*U01DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, HAROLD I · 2001 to 2017
$50.1M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Tulane COBRE in Cardiometabolic Diseases Clinical Research CoreP20GM109036 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI JING CHEN · 2016 to 2026
$25.3M
Zonulin Antibodies in Intestinal Permeabilitiy in IDDMM01RR016500 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI OSWALD, LYNN M · 2002 to 2009
$20.2M
Study of the Care and Outcomes of REnal InsufficiencyU01DK060902 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2001 to 2025
$19.5M
Limited Competition for the Continuation of the Chronic Renal Insufficiency CohorU01DK061021 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI RAHMAN, MAHBOOB · 2001 to 2025
$17.3M
Prospective Renal Insufficiency Cohort Evaluation:PRICEU01DK060984 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI COHEN, DEBBIE L · 2001 to 2025
$17.0M
NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR000424NCATS NIH HHS UL1 TR000433NCATS NIH HHS UL1 TR000439NCATS NIH HHS UL1 TR002548NCATS NIH HHS UL1 TR003098NCRR NIH HHS M01 RR013987NCRR NIH HHS M01 RR016500NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1 RR029879NIDDK NIH HHS R01 DK074151NIDDK NIH HHS R01 DK139225NIDDK NIH HHS R21 DK130018NIDDK NIH HHS U01 DK060902NIDDK NIH HHS U01 DK060963NIDDK NIH HHS U01 DK060980NIDDK NIH HHS U01 DK060984NIDDK NIH HHS U01 DK060990NIDDK NIH HHS U01 DK061021NIDDK NIH HHS U01 DK061022NIDDK NIH HHS U01 DK061028NIGMS NIH HHS P20 GM109036
6 · The paper itself

Abstract

purposeChronic kidney disease (CKD) patients often develop cardiovascular disease (CVD) and retinopathy. The purpose of this study was to assess the association between progression of retinopathy and concurrent incidence of CVD events in participants with CKD.

designWe assessed 1051 out of 1936 participants in the Chronic Renal Insufficiency Cohort Study that were invited to have fundus photographs obtained at two timepoints separated by 3.5 years, on average.

methodsUsing standard protocols, presence and severity of retinopathy (diabetic, hypertensive or other) and vessel diameter calibre were assessed at a retinal image reading centre by trained graders masked to study participants' information. Participants with a self-reported history of CVD were excluded. Incident CVD events were physician adjudicated using medical records and standardised criteria. Kidney function and proteinuria measurements along with CVD risk factors were obtained at study visits.

resultsWorsening of retinopathy by two or more steps in the EDTRS retinopathy grading scale was observed in 9.8% of participants, and was associated with increased risk of incidence of any CVD in analysis adjusting for other CVD and CKD risk factors (OR 2.56, 95% CI 1.25 to 5.22, p<0.01). After imputation of missing data, these values were OR=1.66 (0.87 to 3.16), p=0.12.

conclusionProgression of retinopathy is associated with higher incidence of CVD events, and retinal-vascular pathology may be indicative of macrovascular disease even after adjustment for kidney diseases and CVD risk factors. Assessment of retinal morphology may provide important information when assessing CVD in patients with CKD.

Indexed as

AdultAgedCardiovascular DiseasesDiabetic RetinopathyDisease ProgressionFemaleFollow-Up StudiesGlomerular Filtration RateHumansIncidenceMaleMiddle AgedPhotographyProspective StudiesRenal Insufficiency, ChronicRetinal Vesselsepidemiologyretina

Identifiers

PMID32503932
PMCPMC8371497
OpenAlexW3032898884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.